Cancer Investigation, Volume 20, Issue sup2 (2002)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Cancer Investigation, Volume 20, Issue sup2 (2002)

See all volumes and issues
Vol 42, 2024 Vol 41, 2023 Vol 40, 2022 Vol 39, 2021 Vol 38, 2020 Vol 37, 2019 Vol 36, 2018 Vol 35, 2017 Vol 34, 2016 Vol 33, 2015 Vol 32, 2014 Vol 31, 2013 Vol 30, 2012 Vol 29, 2011 Vol 28, 2010 Vol 27, 2009 Vol 28, 2010 Vol 27, 2009 Vol 26, 2008 Vol 25, 2007 Vol 24, 2006 Vol 23, 2005 Vol 22, 2004 Vol 21, 2003 Volume 20, 2002 Vol 19, 2001 Vol 18, 2000 Vol 17, 1999 Vol 16, 1998 Vol 15, 1997 Vol 14, 1996 Vol 13, 1995 Vol 12, 1994 Vol 11, 1993 Vol 10, 1992 Vol 9, 1991 Vol 8, 1990 Vol 7, 1989 Vol 6, 1988 Vol 5, 1987 Vol 4, 1986 Vol 3, 1985 Vol 2, 1984 Vol 1, 1983
Download citations Download PDFs Download issue

Original

Article
Critical Review of Current Treatment Strategies for Advanced Hormone Insensitive Breast Cancer
Catherine Van Poznak M.D. & Andrew D. Seidman M.D.
Pages: 1-14
Published online: 24 Sep 2002
AbstractforCritical Review of Current Treatment Strategies for Advanced Hormone Insensitive Breast Cancer | Full Text | References | PDF (329.2 KB)
  • 47 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Anti-tumor Effects of Letrozole
W. R. Miller, T. J. Anderson & J. M. Dixon
Pages: 15-21
Published online: 24 Sep 2002
AbstractforAnti-tumor Effects of Letrozole | Full Text | References | PDF (181.7 KB)
  • 148 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Pegylated Liposomal Doxorubicin (Doxil®) for Metastatic Breast Cancer: The Cancer Research Network, Inc., Experience
Alejandra T. Perez M.D., Gabriel H. Domenech M.D., Cynthia Frankel R.N. & Charles L. Vogel M.D.
Pages: 22-29
Published online: 24 Sep 2002
AbstractforPegylated Liposomal Doxorubicin (Doxil®) for Metastatic Breast Cancer: The Cancer Research Network, Inc., Experience | Full Text | References | PDF (152.1 KB)
  • 464 Views
  • 91 CrossRef citations
  • 0Altmetric
Article
Farnesyltransferase Inhibitors in Breast Cancer Therapy
Grace K. Dy M.D. & Alex A. Adjei M.D., Ph.D.
Pages: 30-37
Published online: 24 Sep 2002
AbstractforFarnesyltransferase Inhibitors in Breast Cancer Therapy | Full Text | References | PDF (198.6 KB)
  • 21 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
The Search for Enhanced Therapeutic Index in Breast Cancer: Targeting the Tumor and Modulation of Enzyme Expression
Daniel R. Budman M.D.
Pages: 38-44
Published online: 24 Sep 2002
First Page PreviewforThe Search for Enhanced Therapeutic Index in Breast Cancer: Targeting the Tumor and Modulation of Enzyme Expression | Full Text | References | PDF (314.5 KB)
  • 17 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
The New Bisphosphonate, Zometa® (Zoledronic Acid), Decreases Skeletal Complications in Both Osteolytic and Osteoblastic Lesions: A Comparison to Pamidronate
Allan Lipton, E. Small, Fred Saad, D. Gleason, David Gordon, M. Smith, Lee Rosen, M. Ortu Kowalski, Dirk Reitsma & John Seaman
Pages: 45-54
Published online: 24 Sep 2002
AbstractforThe New Bisphosphonate, Zometa® (Zoledronic Acid), Decreases Skeletal Complications in Both Osteolytic and Osteoblastic Lesions: A Comparison to Pamidronate | Full Text | References | PDF (237.9 KB)
  • 341 Views
  • 142 CrossRef citations
  • 0Altmetric

Explore articles